Home pageIDXX • NASDAQ
add
IDEXX
645,55 $
After Hours:(0,00%)0,00
645,55 $
Data e ora chiusura: 22 ago, 17:20:00 GMT-4 · USD · NASDAQ · Disclaimer
Chiusura precedente
633,05 $
Intervallo giornaliero
634,69 $ - 648,55 $
Intervallo annuale
356,25 $ - 688,12 $
Cap di mercato
51,65 Mld USD
Volume medio
699.917,00
Rapporto P/E
53,73
Dividendo/Prezzo
-
Borsa valori principale
NASDAQ
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 1,11 Mld | 10,55% |
Spese di gestione | 321,69 Mln | 9,47% |
Utile netto | 293,99 Mln | 44,61% |
Margine di profitto netto | 26,50 | 30,80% |
Utili per azione | 3,50 | 15,89% |
EBITDA | 408,82 Mln | 14,36% |
Aliquota fiscale effettiva | 18,87% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 164,59 Mln | -59,01% |
Totale attivo | 3,33 Mld | -2,46% |
Totale passivo | 1,87 Mld | 2,04% |
Patrimonio netto totale | 1,46 Mld | — |
Azioni in circolazione | 80,00 Mln | — |
Prezzo/valore contabile | 34,78 | — |
Redditività dell'attivo | 28,50% | — |
Rendimento sul capitale | 35,85% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 293,99 Mln | 44,61% |
Liquidità di esercizio | 185,74 Mln | -25,20% |
Contanti da investimenti | -33,63 Mln | -2,19% |
Contanti da finanziamenti | -165,63 Mln | 21,22% |
Flusso di cassa netto | 624.000,00 | -84,99% |
Flusso di cassa libero | 118,93 Mln | -53,23% |
Informazioni
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
CEO
Fondazione
19 dic 1983
Sito web
Dipendenti
11.000
